Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation

NCT01138579 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Recruitment delayed, trial medication no loner available

Conditions

Leukemia
Stem Cell Transplantation

Interventions

DRUG: FBTA05

Sponsor

Technical University of Munich